Ryo Mukai1, Taku Sato, Shoji Kishi. Show Affiliations » 1. Ophthalmology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Abstract
Mesh: See more » AgedAged, 80 and overAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useColoring AgentsCombined Modality TherapyFemaleFluorescein AngiographyHumansIndocyanine GreenMalePhotochemotherapyRanibizumabRetinal Perforations/diagnosisRetinal Perforations/etiologyRetinal Pigment Epithelium/pathologyTomography, Optical CoherenceVascular Endothelial Growth Factor A/antagonists & inhibitorsWet Macular Degeneration/complicationsWet Macular Degeneration/drug therapy
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedColoring AgentsVEGFA protein, humanVascular Endothelial Growth Factor AIndocyanine GreenRanibizumab
Year: 2014 PMID: 24460708 DOI: 10.1111/aos.12350
Source DB: PubMed Journal: Acta Ophthalmol ISSN: 1755-375X Impact factor: 3.761